Xylo Research Systems LLC, dba Panda Peptides, is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act
The use of NNMT inhibitors as a potential obesity treatment has been investigated preclinically 8,9,13 , and observational clinical data suggests that increased NNMT expression and activity correlate with increased incidence of Type 2 diabetes (T2D) and risk of obesity, respectively 10,11
Most sellers ship on a suppliers word
Discard if cloudy or showing particulate matter
Both the peptide vial and the BAC water should be at room temperature before you begin reconstitution
AOD9604 (Advanced Obesity Drug) was developed by Professor Frank Ng at Monash University in Australia in the 1990s, with the intent of finding an anti-obesity drug that had the fat-burning effects of human growth hormone